OBJECTIVE: We aim to describe our findings and technique for reducing progression to the second stage of a two-stage augmentation mastopexy with the appropriate use of moderate to high volume of fat grafting at the primary operation.
METHODS: This is a retrospective review of all patients who presented to the senior author (KT) requesting breast implants and requiring mastopexy, from January 2018 to December 2022.
RESULTS: Over the five-year period, 137 patients were identified. Seventy-one (51.8%) underwent single-stage augmentation mastopexy, 55 (40.1%) underwent mastopexy with fat grafting and 11 (8.0%) underwent mastopexy with no fat grafting. Our key finding in this study is that 52 of 66 (78.8%) of planned staged patients, who underwent mastopexy with or without fat grafting, were happy with the volume attained and no longer wished to undergo further implant augmentation.
CONCLUSIONS: In selected patients, appropriate volume and position of fat grafting at the time of primary mastopexy can significantly obviate the need for a second stage implant (alloplastic) augmentation.
METHODS: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
目的:我们的目的是描述我们的发现和技术,以减少进展到第二阶段的两阶段增加乳房固定术,并在初次手术中适当使用中等至大量的脂肪移植。
方法:这是对所有向高级作者(KT)提出要求乳房植入物并需要乳房固定术的患者的回顾性研究,从2018年1月到2022年12月。
结果:在五年期间,确定了137名患者。七十一人(51.8%)接受了单阶段增强乳房固定术,55例(40.1%)进行了脂肪移植的乳房固定术,11例(8.0%)进行了无脂肪移植的乳房固定术。我们在这项研究中的关键发现是,66例计划分期患者中有52例(78.8%),接受乳房固定术有或没有脂肪移植的人,对获得的体积感到满意,不再希望进行进一步的植入物增强。
结论:在选定的患者中,在初次乳房固定术时,适当的脂肪移植体积和位置可以显着消除对第二阶段植入物(同种异体)增强的需要。
方法:本期刊要求作者为每篇文章分配一定程度的证据。对于这些循证医学评级的完整描述,请参阅目录或在线作者说明www。springer.com/00266.